Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Paloma Navarro, Enrique Grande, Ignacio Pérez de Castro, Alvaro Taus, Elena Garcia-Martinez, Zaida Garcia-Casado, Juan Francisco Rodriguez-Moreno, Jose Antonio Lopez-Guerrero, Mario Prieto, Maria Jesus Rubio, Isabel Palacio, Isabel Bover, Juan Cueva, Victor Rodriguez, Eva Guerra, Nuria Lainez, Laura Vidal, Andres Redondo, Ana Santaballa, Laia Garrigos, Alicia Hurtado, Jesus Garcia-Donas
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023;25(7):2090-2098